Company Overview and News

6
IDACORP (IDA) Announces Quarterly Dividend Hike of 6.8%

8h zacks
IDACORP Inc. (IDA - Free Report) recently announced that the board of directors approved a 6.8% quarterly cash dividend increase to 63 cents per share on its common stock. On issuance of the new rate, the annualized dividend will be $2.52 per share, reflecting a dividend yield of 2.54%, better than the Zacks Composite S&P 500’s 1.77%. Regular Dividend Hikes IDACORP has been raising its cash dividend per share every year since 2012.
IDAHOPWR KBH CMSA UNTXP IDA CMS ED UTL

1
Sempra Energy to Sell Renewable Assets for $1.5B to ConEd

2018-09-21 zacks - 1
Sempra Energy (SRE - Free Report) recently announced that it has inked a definitive agreement with Consolidated Edison, Inc. (ED - Free Report) , to divest its U.S.-based renewable portfolio for a total cash of $1.54 billion. The deal includes Sempra Energy’s non-utility operating solar assets, solar and battery storage development projects and one wind facility. However, the deal remains subject to adjustments for working capital and pre-closing cash contributions.
AEE SRE VIVHY UTX ED VIV EOG

 
Sempra Energy Sells Solar Assets for $1.54 Billion

2018-09-21 247wallst
Energy infrastructure and distribution company Sempra Energy (NYSE: SRE) said Thursday morning that it has sold its U.S. non-utility operating solar assets, its solar and battery storage development projects and one wind facility to Consolidated Edison Inc. (NYSE: ED) for $1.54 billion.
SOCGP SRE SOCGM ED SOCG

 
ED / Consolidated Edison, Inc. 8-K (Current Report)

2018-09-20 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
ED

 
ED / Consolidated Edison, Inc. 8-K (Current Report)

2018-09-20 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
ED

1
Con Ed unit to buy Sempra Energy renewable unit for $1.5 billion

2018-09-20 marketwatch - 1
Consolidated Edison Inc. nd said late Thursday that one of its subsidiaries has agreed to buy a Sempra Energy SRE, +0.07% subsidiary for $1.5 billion. The Sempra Energy unit owns renewable electric-production projects, including projects jointly owned Con Edison units and development rights for additional solar and energy-storage projects. The deal is expected to close at the end of the year, Con Edison said.
SRE ED

 
Con Edison to Acquire 981 MW of Renewable Electric Production Projects from Sempra Energy

2018-09-20 globenewswire
NEW YORK, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Consolidated Edison, Inc. (NYSE: ED) (“Con Edison”) today announced that one of its subsidiaries has agreed to acquire a Sempra Energy subsidiary that owns 981 megawatts (MW) AC of operating renewable electric production projects, including its 379 MW AC share of projects that it owns jointly with Con Edison subsidiaries, and certain development rights for additional solar electric production and energy storage projects.
SRE ED

10
AltaGas: Abandoning Canada, Will The Company Win Over U.S. Investors?

2018-09-17 seekingalpha
AltaGas has been consistently investing in U.S. projects over Canadian ones. Recent divestitures to fund the U.S. based WGL Holdings acquisition have tilted Canadian.
SOJA DUKH SO TRP SCG WGL DTK DUK ENB ENB ATGFF EQT WMB TRP ED PBA

 
An old problem: Aging pipelines lead to deadly explosions

2018-09-14 nzherald.co.nz
The natural gas pipeline in the United States is vast, sprawling across 2.5 million miles in a complex pressurized system that delivers a quarter of the energy consumed nationwide, according to the American Gas Association. Many of the pipes are old, and utilities are in various stages of replacing them to improve safety.
ED

25
Pipeline Challenges in U.S. & Canada Continue Amid Oil Boom

2018-09-14 zacks
Oil production is surging in North America but producers are far from happy as their profit margin is sinking. They are struggling to stay competitive owing to the infrastructural bottlenecks. As if the pipeline pinch problem was not enough for the United States and Canada, raging protests against the already approved and existing pipeline projects have made things worse.
DCUB SOJA DCUA DCUD DCUC CY UGI WGL ENB SJIU EQM KMI DRUA TRP EBBNF PAA ED KMR CVB NEE SO ENBBF DUKH TRP SJI D NJR DUK RGCO ENB ETP KMRFZ GJP

 
“It Looked Like Armageddon:” Deadly Gas Blasts Destroy Homes

2018-09-14 thenationalherald
In this image take from video provided by WCVB in Boston, flames consume the roof of a home in Lawrence, Mass, a suburb of Boston, Thursday, Sept. 13, 2018. Emergency crews are responding to what they believe is a series of gas explosions that have damaged homes across three communities north of Boston. (WCVB via AP)
ED

12
Top Research Reports for Oracle, Roche & Goldman Sachs

2018-09-12 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Roche (RHHBY) and Goldman Sachs (GS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
BRK.A CQP PLD LNG KHC ICE ED ORCL

 
Is Consolidated Edison (ED) a High-Growth Dividend Stock?

2018-09-12 zacks
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
CY ED

13
Midstream Out Of Office Washout

2018-09-02 seekingalpha
Midstream had a rough week, the worst since late March and 4th worst so far this year. Oil prices rallied for a second straight week, NGL prices were sharply higher, the broad stock market was higher again, but midstream and MLPs lagged badly.
NGL CCR TGE ENB CEQP GNE EQM KMI TRP WMB AMGP OKE ED KMR CVB GEL NEE TRP VLP RGCO ENB ETP GNE TRGP PBA KMRFZ

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ED / Consolidated Edison, Inc. on message board site Silicon Investor.

Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices
Politics for Pros- moderated Politics for Pros- moderated Politics for Pros- moderated Golf! A thread for the hopelessly addicted! Golf! A thread for the hopelessly addicted! Golf! A thread for the hopelessly addicted!
NFL Prediction Contest NFL Prediction Contest NFL Prediction Contest Media Industries: Newspapers, TV, Radio, Movies, Online Media Industries: Newspapers, TV, Radio, Movies, Online Media Industries: Newspapers, TV, Radio, Movies, Online
International Automated Systems International Automated Systems International Automated Systems The Residential Real Estate Post-Crash Index-Moderated The Residential Real Estate Post-Crash Index-Moderated The Residential Real Estate Post-Crash Index-Moderated
OLED Universal Display Corp OLED Universal Display Corp OLED Universal Display Corp The Woodshed The Woodshed The Woodshed
CUSIP: 209115104